Bruce A. Chabner
1970–2023 年に発表
- 別表記
- BRUCE A. CHABNER
- 90
- 論文数
- 18,582
- 被引用数
- 77
- h 指数
- 90
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Medicine52.3%
- Biochemistry, Genetics and Molecular Biology28.1%
- Neuroscience3.7%
- Materials Science2.6%
- Engineering2.5%
- Immunology and Microbiology2%
- その他8.8%
トピック
- Cancer Genomics and Diagnostics3.9%
- Lymphoma Diagnosis and Treatment3.3%
- Acute Lymphoblastic Leukemia research2.6%
- Lung Cancer Treatments and Mutations1.6%
- Viral-associated cancers and disorders1.4%
- Epigenetics and DNA Methylation1.4%
- その他85.8%
共著者
- J C Drake14
- Robert C. Young14
- Vincent T. DeVita12
- Carmen J. Allegra10
- George P. Canellos7
- Jacques Jolivet6
- Joseph A. Kovacs6
- Philip S. Schein6
- Dan L. Longo5
- Henry Masur5
- Thomas J. Lynch5
- Beverly Moy4
- Elaine S. Jaffe4
- Kenneth R. Hande4
- Martin Gutierrez4
- Richard T. Penson4
- Wyndham H. Wilson4
- Charles E. Myers3
- Gregory A. Curt3
- J C Swan3
- Jerry M. Collins3
- Kenneth H. Cowan3
- Leif W. Ellisen3
- Marc E. Lippman3
全論文
- Chemotherapy and the war on cancer
著者: Bruce A. Chabner, Thomas G. Roberts - Nature reviews. Cancer 2005 被引用: 2,107
- Application of Cell-Free DNA Analysis to Cancer Treatment
著者: Ryan B. Corcoran, Bruce A. Chabner - New England Journal of Medicine 2018 被引用: 970
- Immune Checkpoint Inhibitors — The Need for Innovation
著者: P. Connor Johnson, Justin F. Gainor, Ryan J. Sullivan, Dan L. Longo, Bruce A. Chabner - New England Journal of Medicine 2023 被引用: 49
- Histone Deacetylase Inhibitors in Cancer Therapy
著者: Andrew A. Lane, Bruce A. Chabner - Journal of Clinical Oncology 2009 被引用: 872
- Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition
著者: Bob T. Li, Bobby Daly, Mary Gospodarowicz, Monica M. Bertagnolli, Otis W. Brawley, Bruce A. Chabner, Lola A. Fashoyin‐Aje, R. Angelo de Claro, Elizabeth Franklin, Jennifer S. Mills, Jeff Legos, Karen Kaucic, Mark Junjie Li, Lydia Thé, Tina Hou, Tinghui Wu, Björn Albrecht, Yi Shao, Justin Finnegan, Jing Qian, Javad Shahidi, Eduard Gasal, Craig Tendler, Geoffrey Kim, James Yan, Phuong K. Morrow, Charles S. Fuchs, Lianshan Zhang, Robert LaCaze, Stefan Oelrich, Martin J. Murphy, Richard Pazdur, Kevin Rudd, Yi‐Long Wu - Nature Medicine 2022 被引用: 52
- HIV Infection and Survival Among Women With Cervical Cancer
著者: Scott Dryden‐Peterson, Memory Bvochora‐Nsingo, Gita Suneja, Jason A. Efstathiou, Surbhi Grover, Sebathu Chiyapo, Doreen Ramogola‐Masire, Malebogo Kebabonye-Pusoentsi, R.H. Clayman, Abigail C. Mapes, Neo Tapela, Aida Asmelash, Heluf Medhin, Akila N. Viswanathan, Anthony H. Russell, Lilie L. Lin, Mukendi Kayembe, Mompati Mmalane, Thomas C. Randall, Bruce A. Chabner, Shahin Lockman - Journal of Clinical Oncology 2016 被引用: 207
- The Pharmacology and Clinical Use of Methotrexate
著者: Jacques Jolivet, Kenneth H. Cowan, Gregory A. Curt, Neil J. Clendeninn, Bruce A. Chabner - New England Journal of Medicine 1983 被引用: 786
- Antibody–Drug Conjugates for the Treatment of Solid Tumors: Clinical Experience and Latest Developments
著者: Aiko Nagayama, Leif W. Ellisen, Bruce A. Chabner, Aditya Bardia - Targeted Oncology 2017 被引用: 102
- Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity Intervention
著者: Ryan David Nipp, Hang Lee, Emily Gorton, Morgan RL Lichtenstein, Salome Kuchukhidze, Elyse R. Park, Bruce A. Chabner, Beverly Moy - The Oncologist 2019 被引用: 79
- Design and clinical validation of a point-of-care device for the diagnosis of lymphoma via contrast-enhanced microholography and machine learning
著者: Hyungsoon Im, Divya Pathania, Philip J. McFarland, Aliyah R. Sohani, Ismail Degani, Matthew J. Allen, Benjamin Coble, Aoife Kilcoyne, Seonki Hong, Lucas Rohrer, Jeremy S. Abramson, Scott Dryden‐Peterson, Lioubov Fexon, Misha Pivovarov, Bruce A. Chabner, Hakho Lee, Cesar M. Castro, Ralph Weissleder - Nature Biomedical Engineering 2018 被引用: 83
- Polyglutamation of methotrexate. Is methotrexate a prodrug?
著者: Bruce A. Chabner, Carmen J. Allegra, Gregory A. Curt, Neil J. Clendeninn, Jacob Baram, Satoshi Koizumi, J C Drake, Jacques Jolivet - Journal of Clinical Investigation 1985 被引用: 467
- Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast Cancer
著者: Marko Velimirovic, Dejan Juric, Andrzej Niemierko, Laura M. Spring, Neelima Vidula, Seth A. Wander, Arielle J. Medford, Aparna R. Parikh, Giuliana Malvarosa, Megan Yuen, Ryan B. Corcoran, Beverly Moy, Steven J. Isakoff, Leif W. Ellisen, A. John Iafrate, Bruce A. Chabner, Aditya Bardia - JCO Precision Oncology 2020 被引用: 24
- Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy
著者: Wyndham H. Wilson, Michael L. Grossbard, Stefania Pittaluga, Diane E. Cole, Deborah A. Pearson, Nicole Drbohlav, Seth M. Steinberg, Richard F. Little, John E. Janik, Martin Gutierrez, Mark Raffeld, Louis M. Staudt, Bruce D. Cheson, Dan L. Longo, Nancy L. Harris, Elaine S. Jaffe, Bruce A. Chabner, Robert E. Wittes, Frank M. Balis - Blood 2002 被引用: 330
- Improving Prospects for Targeting RAS
著者: Harshabad Singh, Dan L. Longo, Bruce A. Chabner - Journal of Clinical Oncology 2015 被引用: 110
- Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program
著者: Ryan David Nipp, Hang Lee, Elizabeth E. Powell, Nicole Birrer, Emily Poles, Daniel Finkelstein, Karen M. Winkfield, Sanja Percac‐Lima, Bruce A. Chabner, Beverly Moy - The Oncologist 2016 被引用: 97
- NCI-60 Cell Line Screening: A Radical Departure in its Time
著者: Bruce A. Chabner - JNCI Journal of the National Cancer Institute 2016 被引用: 86
- Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase.
著者: Edward Chu, David M. Koeller, John Casey, J C Drake, Bruce A. Chabner, Patrick C. Elwood, S Zinn, Carmen J. Allegra - National Academy of Sciences, Proceedings of the National Academy of Sciences 1991 被引用: 385
- ERBB2 Inhibition and Heart Failure
著者: Gregory M. Coté, Douglas B. Sawyer, Bruce A. Chabner - New England Journal of Medicine 2012 被引用: 101
- Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate Toxicity
著者: Ronald G. Stoller, Kenneth R. Hande, Samuel A. Jacobs, Steven A. Rosenberg, Bruce A. Chabner - New England Journal of Medicine 1977 被引用: 400
- Concepts in use of high-dose methotrexate therapy
著者: Steven P. Treon, Bruce A. Chabner - Clinical Chemistry 1996 被引用: 185
- Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations
著者: Jing Xu, Tanya E. Keenan, Beth Overmoyer, Nadine Tung, Rebecca Gelman, Karleen Habin, Judy E. Garber, Leif W. Ellisen, Eric P. Winer, Paul E. Goss, Beow Y. Yeap, Bruce A. Chabner, Steven J. Isakoff - Breast Cancer Research and Treatment 2021 被引用: 22
- Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates.
著者: Carmen J. Allegra, J C Drake, Jacques Jolivet, Bruce A. Chabner - National Academy of Sciences, Proceedings of the National Academy of Sciences 1985 被引用: 313
- 7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate.
著者: Samuel A. Jacobs, Ronald G. Stoller, Bruce A. Chabner, D G Johns - Journal of Clinical Investigation 1976 被引用: 256
- Advantages of a Truly Open-Access Data-Sharing Model
著者: Monica M. Bertagnolli, Oliver Sartor, Bruce A. Chabner, Mace L. Rothenberg, Sean Khozin, Charles Hugh-Jones, David Reese, Martin J. Murphy - New England Journal of Medicine 2017 被引用: 95
